Associations between neurofilament light chain levels, disease activity and brain atrophy in progressive multiple sclerosis.
Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia(2022)
摘要
The results show that pNfL levels are a useful biomarker of disease activity determined by NEDA-3 status, including brain MRI-volumetry, in patients with the progressive form of MS.
更多查看译文
关键词
brain volume loss,multiple sclerosis,neurofilament light chain,no evident disease activity,progressive MS
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要